In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to establish Harmless dosing routine. Further participants will be enrolled within the determined monotherapy dosign regimen. In Section B, participants will obtain oral ruxolitinib and ABBV-744 are going to be specifi